A protein-based set of reference markers for liver tissues and hepatocellular carcinoma

BMC Cancer

Table 2 The expressions of beta-actin and HSP60 in different clinicopathological subgroups of HCC tumour tissues.

Clinicopathological parameters	n = 105	Beta-actin		HSP60
		Mean intensity (ppm)	pvalue	Mean intensity (ppm)	pvalue
Gender
Male	89	7.60 ± 0.95	0.81^a	7.77 ± 1.06	0.63^a
Female	16	7.59 ± 0.93		7.70 ± 0.93
Age (years)
≥60	38	7.61 ± 0.81	0.76^a	7.48 ± 0.74	0.67^a
< 60	67	7.58 ± 1.01		7.76 ± 1.17
Tumour size (cm)
> 2	69	7.79 ± 0.96	0.17^a	7.68 ± 0.98	0.91^a
≤2	36	7.40 ± 0.89		7.79 ± 1.14
Venous infiltration
Yes	58	7.53 ± 0.71	0.61^a	7.58 ± 0.73	0.36^a
No	57	7.65 ± 1.01		7.89 ± 0.87
New TNM stage
Stage I-II	69	7.72 ± 1.10	0.38^a	7.58 ± 0.99	0.75^a
Stage III-IV	36	7.47 ± 0.84		7.70 ± 1.14
New Edmonson Grade
Well differentiated	27	7.49 ± 1.37	0.39^b	7.68 ± 1.37	0.97^b
Moderately differentiated	60	7.51 ± 0.94		7.76 ± 0.77
Poorly differentiated	18	7.79 ± 0.71		7.77 ± 0.73

ISSN: 1471-2407